Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-04 Sale | 2024-01-05 6:26 pm | Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel | 10,676 | $1.1836 | $12,636 | 928,966 (Direct) | View |
| 2020-10-14 Purchase | 2020-10-16 3:40 pm | Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel | 5,250 | $19 | $99,750 | 614,600 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-24 Option Award | 2024-05-24 6:58 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | Kosacz Barbara Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 4:30 pm | N/A 2034-05-15 | XOMA Corp | XOMA | Kosacz Barbara Director | 9,763 | $0 | 9,763 (Direct) | View |
| 2024-02-14 Other | 2024-02-16 7:40 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Kosacz Barbara Director | 5,828 | $0 | 11,656 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 6:06 pm | N/A 2033-05-18 | Athira Pharma Inc. | ATHA | Kosacz Barbara Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:30 pm | N/A 2033-05-17 | XOMA Corp | XOMA | Kosacz Barbara Director | 10,967 | $0 | 10,967 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:19 pm | N/A 2033-02-14 | Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel | 347,278 | $0 | 1,148,009 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 6:18 pm | N/A N/A | Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel | 53,600 | $0 | 791,624 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-27 5:47 pm | N/A 2032-05-19 | Athira Pharma Inc. | ATHA | Kosacz Barbara Director | 13,871 | $0 | 13,871 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 09:00 am | N/A 2032-05-18 | XOMA Corp | XOMA | Kosacz Barbara Director | 8,996 | $0 | 8,996 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:23 pm | N/A 2032-02-14 | Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel | 133,600 | $0 | 818,024 (Direct) | View |
| 2021-10-08 Other | 2021-10-12 7:24 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Kosacz Barbara Director | 17,500 | $0 | 17,500 (Indirect) | View |
| 2021-05-19 Option Award | 2021-05-21 4:30 pm | N/A 2031-05-19 | XOMA Corp | XOMA | Kosacz Barbara Director | 5,101 | $0 | 5,101 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 4:38 pm | N/A 2031-03-03 | Athira Pharma Inc. | ATHA | Kosacz Barbara Director | 27,742 | $0 | 27,742 (Direct) | View |
Ownership | 2021-03-08 4:29 pm | N/A N/A | Athira Pharma Inc. | ATHA | Kosacz Barbara Director | 0 | $0 | 0 (Direct) | View |
| 2021-01-12 Other | 2021-01-14 7:50 pm | N/A N/A | Locust Walk Acquisition Corp. | LWAC | Kosacz Barbara Director | 17,500 | $0 | 17,500 (Indirect) | View |
| 2020-12-09 Option Award | 2020-12-11 4:35 pm | N/A 2030-12-08 | Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel | 174,560 | $0 | 789,160 (Direct) | View |
Ownership | 2020-10-08 7:06 pm | N/A N/A | Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel | 0 | $0 | 609,350 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-27 2:30 pm | N/A 2030-05-20 | XOMA Corp | XOMA | Kosacz Barbara Director | 6,152 | $0 | 6,152 (Direct) | View |